Your browser doesn't support javascript.
Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine.
Yamamoto, Shohei; Tanaka, Akihito; Oshiro, Yusuke; Inamura, Natsumi; Mizoue, Tetsuya; Ohmagari, Norio.
  • Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Tanaka A; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Oshiro Y; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Inamura N; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. mizoue@hosp.ncgm.go.jp.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Infection ; 2022 Aug 04.
Article in English | MEDLINE | ID: covidwho-2287410
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: S15010-022-01898-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: S15010-022-01898-5